cerrar
Tagged with Investment

Interview: Roberto Bellini, President & CEO, Bellus Health,…
The CEO of Bellus Health outlines his strategy since 2010 to change the focus of the company from Alzheimer’s to a niche disease, AA amyloidosis, as…

Interview: Raphael Hofstein, President & CEO, MaRS…
The CEO of MaRS Innovation, a commercialization incubator created by 16 of Toronto's best research institutions and supported by the government,…

Nicolas Marceau – Minister of Finance & Economy,…
Minister Marceau addresses the changes in policy in Quebec relating to the pharmaceutical and life sciences sectors, and the incentives in place to…

Interview: Paul Glover, Associate Deputy Minister, Health Canada
A perspective from Canada’s national health body on the future of medicine in the 21st century, from the shift to personalized medicine to…

Interview: Johnsee Lee, Chairman, Development Center for…
A leading figure in the Taiwanese pharmaceutical sector, Lee divulges the practicalities behind ECFA, the free trade agreement that was signed between…

Colombia: Confidence in uncertainty
Under the administration of President Juan Manuel Santos, Colombia is focusing on bolstering the commercial sector. While this is good news for the…

Interview: Andrew Casey, CEO, BIOTECanada
BIOTECanada is the national trade association for Canada’s biotech industry. Andrew Casey, the group’s CEO, discusses the impact of IP regulation…

The 3 T’s: Positioning Ireland for FDI
What makes Ireland attractive for FDI? As the former general manager of Genzyme‰Ûªs Waterford site, Pat O‰ÛªSullivan explains that a…

Ireland: up the ladder
Lilly set up in Ireland three decades ago by purchasing a farm. In its early days, the operation produced intermediaries for small-molecule drugs.…

From foreign investment, Irish companies
FDI into Ireland has created a feedstock for the indigenous ecosystem: raising the bar for standards and technology, contributing to the experience of…

Interview: Thomas Willemsen, Vice President and General Manager,…
In Taiwan, GSK recently signed Memorandum of Understanding with the National Research Program of Biopharmaceuticals (NRPB), building on research…

Interview: Pia Olsen Dyhr, Minister of Trade & Investment,…
Pia Olsen Dyhr is a member of the Danish Folketing (Parliament) for the Socialist People’s Party in the North Zealand greater constituency, as well…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here